Search results for "Colorectal cancer"
In persons aged ≥45 y, the mt-sRNA test had 94% sensitivity for colorectal cancer and 46% for advanced adenomas
The results of the industry-funded study support the use of the multitarget stool RNA (mt-sRNA) test for screening, but better adherence will be needed, and it is unclear whether the new test offers any advantages over current stool DNA testing, an ACP Journal Club commentary said.
https://gastroenterology.acponline.org/archives/2024/02/23/6.htm
23 Feb 2024
Start screening for colorectal cancer at age 50 years, ACP suggests
An update of ACP's 2019 guidance statement on the topic suggests that clinicians start screening for colorectal cancer in asymptomatic average-risk adults at age 50 years and consider not screening those between the ages of 45 and 49 years.
https://gastroenterology.acponline.org/archives/2023/08/25/6.htm
25 Aug 2023
Noninvasive methods show promise for CRC screening
A DNA blood-based test had approximately 83% sensitivity for colorectal cancer (CRC) and 13% sensitivity for advanced precancerous lesions in one industry-funded study, while a next-generation multitarget stool DNA test showed higher sensitivity but lower specificity for CRC and advanced precancerous lesions than fecal immunochemical testing in another.
https://gastroenterology.acponline.org/archives/2024/03/22/1.htm
22 Mar 2024
New guideline encourages less colorectal cancer screening for low-risk patients
The guideline, developed by the BMJ Rapid Recommendations project, suggested no screening for individuals ages 50 to 79 years with an estimated 15-year colorectal cancer risk below 3%.
https://gastroenterology.acponline.org/archives/2019/10/25/2.htm
25 Oct 2019
Recent coverage explores how to increase colorectal cancer screening
Overall colorectal cancer screening rates in the U.S. have increased in recent years but continue to lag behind goal levels, a cover story in the January ACP Internist reported.
https://gastroenterology.acponline.org/archives/2019/01/25/6.htm
25 Jan 2019
Earlier colorectal cancer screening recommended for patients with cystic fibrosis
The Cystic Fibrosis Colorectal Cancer Screening Task Force based its recommendations on a review of the literature and a modeling study of screening strategies for colorectal cancer that estimated the costs and benefits of screening in patients with cystic fibrosis.
https://gastroenterology.acponline.org/archives/2018/01/26/3.htm
26 Jan 2018
Colorectal cancer screening offering colonoscopy and FIT vs. colonoscopy alone improved participation
Results of a Polish trial corroborate studies showing that noninvasive tests, such as fecal immunochemical testing (FIT), or screening choice increases colorectal cancer screening participation over colonoscopy, an ACP Journal Club commentary said.
https://gastroenterology.acponline.org/archives/2021/07/23/6.htm
23 Jul 2021
Middle-age adults getting less colorectal cancer screening than retirement-age adults
Specific population-based efforts to increase colorectal cancer screening are needed so that patients start at age 50 years and continue through age 75 years for the most benefit, study authors said.
https://gastroenterology.acponline.org/archives/2020/03/27/7.htm
27 Mar 2020
Flexible sigmoidoscopy associated with long-term reduction in colorectal cancer incidence, mortality
Colorectal cancer incidence and mortality were reduced by about 20% in patients who were randomized to receive once-only flexible sigmoidoscopy screening between the ages of 55 to 64 years instead of usual care.
https://gastroenterology.acponline.org/archives/2021/11/19/6.htm
19 Nov 2021
Single sigmoidoscopy screening may reduce colorectal cancer, mortality in men but not women
Patients in Norway were randomly assigned to flexible sigmoidoscopy with and without additional fecal blood testing (with colonoscopy offered if results were positive) and were compared to patients offered no screening.
https://gastroenterology.acponline.org/archives/2018/04/27/5.htm
27 Apr 2018